Ticker Symbol Company Name

Research

At B. Riley, the research process is an interactive one where we perform extensive due diligence on companies until the analyst develops the knowledge base and understanding of the company and the industry to make a recommendation. Our analysts continuously monitor industry developments and communicate with the management, competitors, suppliers and customers of the companies we follow, regularly communicating our findings through Research Updates and daily Morning Notes. While we do not necessarily publish research on all of the companies we review, the knowledge base and understanding of many of our monitored companies parallels that of our covered companies. We actively cover over 100 companies and monitor an additional 100.

| Coverage List

Our analysts cover over 100 small to mid-cap companies that are under-followed or misunderstood by Wall Street. We believe that the pricing of small cap equities is frequently inefficient, and therefore provides the greatest potential rewards to diligent security analysis.

| Our Team

| Login to Access Our Equity Research

This Week's Research


Date	Type	Headline
07/29/2010	Update	WIBC ($8.00, Neutral): Loan sales and charge-offs prepare Wilshire for profitable 2H10. Reaffirm "Neutral" rating.	View Document

07/29/2010	Update	CLFC ($5.18*, Buy): Beats 2Q10 Estimates With Lower Provision, Bargain Purchase Gain. Reiterating "Buy" Rating	View Document

07/29/2010	Update	SUSQ ($8.73*, N/A): Review of 2Q10 Results	View Document

07/29/2010	Morning Note	B. Riley & Co. Morning Notes: ACTU, CATY, DRCO, EGHT, ELNK, EWBC, EXAR, LOOP, NARA, NEWP, OPLK, PPC, SIMO, TRMK, UNCA, WIBC	View Document

07/29/2010	Update	TRMK ($22.33, Neutral): Several positive developments in Q2; reaffirming "Neutral" rating	View Document

07/29/2010	Update	EGHT ($1.49, Buy): Raising estimates as EGHT kick starts FY '11 with an across-the-board beat in Q1 (Jun)	View Document

07/29/2010	Update	NEWP ($10.83, Buy): Strong Q2 Results; Raising PT and Maintain "Buy"	View Document

07/29/2010	Update	CATY ($11.67, Neutral): Reports Better-Than-Expected 2Q10 Results. Reaffirm "Neutral" Rating.	View Document

07/29/2010	Initiation of Coverage	SIX ($32.54, Buy): B. Riley & Co. Initiation of Coverage: Initiating Coverage on Six Flags Entertainment Corporation with a "Buy" Rating and $45.00 Price Target	View Document

07/28/2010	Update	ELNK ($8.92, Buy): The tree fell in the forest, but not many heard; It may take New Edge monetization to get fair value for a still-outperforming ELNK	View Document

07/28/2010	Update	SBNY ($38.70, Buy): Reports Robust Results Despite Temporary NIM Compression; Reaffirming "Buy" Rating	View Document

07/28/2010	Update	EWBC ($15.88*, Buy): 2Q10 Results Demonstrate Positive Earnings Momentum. Reiterating "Buy" Rating	View Document

07/28/2010	Update	UMPQ ($12.75, Buy): 2Q10 Results Show Continued Improvements in Asset Quality. Reiterating "Buy" Rating.	View Document

07/28/2010	Update	TRMK ($22.30*, Neutral): Several Positive Developments in Q2 - Reaffirming "Neutral" Rating	View Document

07/28/2010	Update	KEYN ($9.49, Buy): Reports Q3 '10 Results; Reiterate "Buy" Rating	View Document

07/28/2010	Update	SNAK ($3.30; Buy): Reports Q2 Results; Jamba National with WMT, SWY, TGT	View Document

07/28/2010	Morning Note	B. Riley & Co. Morning Notes: AXTI, COHR, DRCO, EGHT, ELNK, FBP, FNB, SNAK, KEYN, LOOP, OCLR, PVSW, SBNY, SHOO, UMPQ, VLCM, WTSLA, WSFS	View Document

07/28/2010	Update	WSFS ($38.24, Buy): Reports Improved Results & Asset Quality Stabilization - Reaffirming "Buy" Rating	View Document

07/28/2010	Update	NARA ($7.40, Buy): Aggressive Problem Loan Actions Result in Large 2Q10 Loss, but Better Positions Company for Future. Reiterating "Buy" Rating	View Document

07/28/2010	Update	LOOP ($12.39; Neutral): Reports Q2 Results; Update on Industry Conditions	View Document

07/28/2010	Update	PVSW ($4.81, Buy): Reports Q4 '10 Results; Reiterate "Buy" Rating	View Document

07/28/2010	Update	FBP ($0.61, Buy): Posts Larger-Than-Expected Loss, but Positive Asset Quality Trends. Reiterating "Buy" Rating.	View Document

07/27/2010	Update	RNST ($15.39, Buy): RNST announces FDIC acquisition & capital raise; reaffirming "Buy" rating	View Document

07/27/2010	Update	PCTI ($6.03, Buy): PCTI beats, raises; increasing price target to $6.93	View Document

07/27/2010	Update	BOH ($50.29, Neutral): Announces Strong 2Q10 Results and Resumption of Share Buyback Program. Reaffirming "Neutral" Rating.	View Document

07/27/2010	Morning Note	B. Riley & Co. Morning Notes: BOH, CALD, CATY, CLFC, CPF, CVBF, EPIC, EWBC, FBP, FNB, MSPD, NARA, NEWP, PCTI, PFBC, RNST, STMP	View Document

07/27/2010	Update	FNB ($8.64*, Buy): FNB Reports Improved Q2 Results – Upgrading to "Buy" on Highly Attractive Dividend Yield & Lower Perceived Risks	View Document

07/27/2010	Update	MSPD ($8.80, Neutral): Announced June quarter results and provided September quarter guidance	View Document

07/26/2010	Update	BPOP($2.62, Buy): Raising EPS Estimates and Target Price Following Encouraging Asset Quality Trends. Reiterating "Buy" Rating	View Document

07/26/2010	Update	PRSP($33.68, Buy): Reports Another Solid Quarter - Reaffirming "Buy" Rating	View Document

07/26/2010	Update	WL($9.88, Neutral): Reports Huge Loss on Mounting Credit Woes; Downgrading to "Neutral"	View Document

07/26/2010	Update	TBBK ($7.63*, Buy): Reducing Estimates & Maintaining "Buy" Rating on Steeply Discounted Valuation	View Document

07/26/2010	Morning Note	B. Riley & Co. Morning Notes: BPOP, ELNK, GBCI, HOMB, IBKC, KEYN, PVSW, PRSP, Q2 '10 Earnings Preview Update, RNST, SABA, SBNY, TCBI, TRMK, WL	View Document

07/26/2010	Update	Q2 '10 Earnings Preview - Sorted by Name	View Document

07/26/2010	Update	Q2 '10 Earnings Preview - Sorted by Date	View Document

07/26/2010	Update	IBKC($50.21, Buy): Review of Q2 Results & FDIC Acquisition - Reaffirming "Buy" Rating	View Document

07/23/2010	Update	CYN ($53.00, Neutral): CYN – Asset quality continues to improve, leading to strong 2Q10 performance. Reiterating "Neutral" rating.	View Document

07/23/2010	Update	ITI ($1.46, N/A): Q1 earnings beat; Strong sensors business; Systems remains soft due to budgetary constraints; P&L turnaround has begun.	View Document

07/23/2010	Update	CSGP ($42.42; Buy): CSGP Beats and Raises Guidance; Reiterate “Buy” Rating	View Document

07/23/2010	Update	HBHC ($28.79, Buy): Reports Miss on Disappointing Asset Quality - Reaffirming "Buy" Rating on Valuation	View Document

07/23/2010	Update	GBCI ($16.19*, Buy): 2Q10 Results Show Asset Quality Improvements. Reaffirming "Buy" Rating	View Document

07/23/2010	Update	HOMB ($22.63*, Neutral): HOMB Announces Strong 2Q10 Results - Maintain "Neutral" Rating	View Document

07/23/2010	Update	TCBI ($15.21*, Buy): NPAs/Assets Increased, But There Are Signs of Stabilization - Reaffirming "Buy" Rating	View Document

07/23/2010	Morning Note	B. Riley & Co. Morning Notes: AFOP, AXTI, CSGP, CYN, DRCO, FNB, GBCI, HBHC, ITI, KEYN, KTOS, OPNT, Optical Component Industry, PCTI, STEC, WSFS	View Document

07/23/2010	Update	AFOP ($1.55, Buy): Strong Q2 results; Reiterate Buy	View Document